首页 › 基金 › SABBY MANAGEMENT, LLC › INM
SABBY MANAGEMENT, LLC 对 INM 的持仓历史
InMed Pharmaceuticals Inc · 医疗保健
SABBY MANAGEMENT, LLC 在 Q2 2026 的 13F 申报中披露持有 INM(InMed Pharmaceuticals Inc)44,970 股,市值约 US$70K,约占其申报组合的 0.51%,在其申报持仓中市值排名第 16 位。 SABBY MANAGEMENT, LLC 最近 11 个申报季度中有 7 个季度披露了 INM 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
SABBY MANAGEMENT, LLC 对 INM 的持仓演变
SABBY MANAGEMENT, LLC 于 Q4 2023 首次披露 INM 持仓:511,934 股(约 US$213.0M)。 在 7 次申报中,SABBY MANAGEMENT, LLC 1 次增持、4 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 44,970 股、市值约 US$70K,环比减持 -175,290 股。。 持仓曾出现大幅变动:Q1 2024 减持约 29% (随后一个季度股价下跌 27%)、Q2 2026 减持约 80% (随后一个季度股价下跌 12%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 511.93K | $212.97M | 新进 |
| Q1 2024 | 361.73K | $131.67K | 减持 |
| Q2 2024 | 307.24K | $81.57K | 减持 |
| Q3 2025 | 220.00K | $481.80K | 新进 |
| Q4 2025 | 201.63K | $213.73K | 减持 |
| Q1 2026 | 220.26K | $142.05K | 增持 |
| Q2 2026 | 44.97K | $69.70K | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 INM 与 13F 数据
INM(InMed Pharmaceuticals Inc)属于医疗保健行业。我们追踪的基金中还有 19 只申报持有 INM,申报仓位最大的包括:Vivo Capital, LLC (US$1.2M), Squadron Capital Management LLC (US$504K), Ursa Fund Management, LLC (US$195K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 INM 的基金
- Vivo Capital, LLC 798.38K 股 · $1.24M · Q2 2026
- Squadron Capital Management LLC 325.00K 股 · $503.75K · Q2 2026
- Ursa Fund Management, LLC 125.80K 股 · $194.99K · Q2 2026
- Venrock Adviser, LLC 32.69K 股 · $50.66K · Q2 2026
更多关于 SABBY MANAGEMENT, LLC
常见问题
How long has SABBY MANAGEMENT, LLC held INM?
SABBY MANAGEMENT, LLC has disclosed INM holdings in 7 of the last 11 reported quarters, going back to Q4 2023.
What is SABBY MANAGEMENT, LLC's current position in INM?
As of Q2 2026, SABBY MANAGEMENT, LLC holds 44.97K shares of INM (InMed Pharmaceuticals Inc), valued at $69.70K, representing 0.51% of its reported portfolio and ranking #16.
Has SABBY MANAGEMENT, LLC been buying or selling INM?
In the latest 13F filing (Q2 2026), SABBY MANAGEMENT, LLC reduced its position in INM.
Which other funds hold INM?
Other major institutional holders of INM include Vivo Capital, LLC, Squadron Capital Management LLC, Ursa Fund Management, LLC, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.